EN|RU|UK
  19071

 Israeli pharmaceutical giant Teva to pay $519 million fine in US for bribing Ukrainian and Russian officials

The company paid millions of dollars in bribes to officials in Mexico, Russia and Ukraine to promote its products such as its blockbuster multiple sclerosis drug Copaxone.

Censor.NET reports citing Reuters.

Teva Pharmaceutical Industries agreed to pay more than $519 million to settle U.S. criminal and civil allegations that the company bribed foreign officials to gain business for its medications, the U.S. Department of Justice said on Thursday.

The company paid millions of dollars in bribes to officials in Mexico, Russia and Ukraine to promote its products such as its blockbuster multiple sclerosis drug Copaxone, the Justice Department said.

Teva will pay a $283 million penalty to settle Foreign Corrupt Practices Act allegations with the Justice Department. The company will also forfeit $236 million in profits plus interest to resolve a civil investigation by the U.S. Securities and Exchange Commission. Teva's Russia subsidiary pleaded guilty to conspiring to violate the Foreign Corrupt Practices Act.

Read more: Corruption harms Ukraine stronger than war with Russia, - Lithuania's Grybauskaite

Teva admitted that its executives bribed officials in order to win more than $65 million in inflated, "corrupt" profits in Russia.

Teva also admitted to bribing a Ukrainian government official in order to gain approval for the sale of the company's drugs.

The briberies took place for more than a decade, according to the Justice Department.

The SEC said that all told the company's bribe scheme brought the company more than $200 million in illicit profits.

Teva said that since 2012 it had taken several steps to address issues of governance, including naming a global head of compliance and ending problematic business relationships.

Read more: "Dear, where did you get the money?"- Poroshenko asks officials to explain their fortunes

Teva, the world's biggest generic drugmaker, said none of the workers involved in the improper payments were any longer with the company, and that it had replaced its entire leadership team in Russia in 2013.

Reuters reported earlier this month that Teva was investigating claims by an anonymous tipster that the company bribed state healthcare workers in Romania.




Источник: https://en.censor.net.ua/n420673
 
 
 
 up